Open access · US-GOV
via ClinicalTrials.gov Clinical trial
The Effect of NICE Support Program on Frailty and Quality of Life in Patients With Heart Failure
Authors not listed
Ai-Fu Chiou · 2022
Abstract
This RCT study aims to examine effects of a NICE Support Program in heart failure patients.
The following hypotheses were tested: patients who received the NICE program will report significant improvement in frailty , social support, anxiety, and depression, quality of life, and nutritional assessment at baseline,4 weeks, 12 weeks and 24 weeks.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Anonymous. (2022). The Effect of NICE Support Program on Frailty and Quality of Life in Patients With Heart Failure. <em>Ai-Fu Chiou</em>. https://clinicaltrials.gov/study/NCT05366686
Vancouver
Anonymous. The Effect of NICE Support Program on Frailty and Quality of Life in Patients With Heart Failure. Ai-Fu Chiou. 2022.
BibTeX
@misc{anon2022TheEff,
title = {The Effect of NICE Support Program on Frailty and Quality of Life in Patients With Heart Failure},
author = {Anonymous},
journal = {Ai-Fu Chiou},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Yang Ming Chiao Tung University 2023
Open access · US-GOV
Development of Family-based Frailty Selfmanagement Model and the Effects of the FRAIL-SM Program Among Patients With Heart Failure
National Yang Ming Chiao Tung University 2019
Open access · US-GOV
Effects of a Multidimensional Exercise Program on Cardiac Surgery Patients
National Taiwan University Hospital 2025
Open access · US-GOV
Effectiveness of a Home-base Walking Exercise Program on Depression,Frailty,and Quality of Life in Patients With Heart Failure: A Single-Center Randomized-Controlled Trial
Hull University Teaching Hospitals NHS Trust 2016
Open access · US-GOV
Assessment of Frailty in Elderly People With Ischemic Heart Disease Being Considered for Revascularisation.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 2000
Open access · US-GOV
Long Term Safety and Efficacy of Galantamine in Alzheimer's Disease (Extension INT-8)
Zhejiang Hospital 2023
Open access · US-GOV